ATYR
aTyr Pharma, Inc.
0.3376$
-10.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 0.13 | 1.14 | 0.00 | 0.37 | 0.01 | 0.00 | 0.00 | |
| 0.01 | – | – | – | 0.53 | 0.39 | 0.35 | 4.19 | 1.89 | 0.07 | 0.06 | 0.05 | 0.02 | 0.02 | |
| -0.01 | – | – | – | -0.53 | -0.39 | -0.35 | -4.06 | -0.75 | -0.07 | 0.31 | 0.01 | 0.00 | -0.01 | |
| 0.20 | 253.88 | 281.55 | 30.50 | 26.16 | 16.32 | 9.53 | 4.19 | 1.89 | 1.22 | 1.51 | 0.79 | 0.73 | 0.65 | |
| – | 104.80 | 113.73 | 11.59 | – | – | – | 2.79 | 0.99 | 0.56 | 0.49 | 0.24 | 0.19 | 0.19 | |
| 0.31 | 358.68 | 395.29 | 42.09 | 34.55 | 25.20 | 14.99 | 2.79 | 0.99 | 1.71 | 1.94 | 1.03 | 0.92 | 0.82 | |
| -0.32 | -358.68 | -395.29 | -42.09 | -35.08 | -25.58 | -15.34 | -6.85 | -1.74 | -1.78 | -1.63 | -1.02 | -0.91 | -0.83 | |
| 0.01 | 8.15 | 13.96 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.33 | -367.34 | -408.65 | -42.40 | -34.23 | -26.16 | -16.13 | -7.08 | -1.77 | -1.77 | -1.60 | -0.94 | -0.86 | -0.80 | |
| – | – | – | – | -0.03 | – | 0.00 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| -0.45 | -367.34 | -408.65 | -42.40 | -34.20 | -26.16 | -16.13 | -7.03 | -1.77 | -1.77 | -1.60 | -0.94 | -0.86 | -0.80 | |
| -0.31 | -345.58 | -381.38 | -40.08 | -33.70 | -25.20 | -14.99 | -6.66 | -1.60 | -1.70 | -1.54 | -0.89 | -0.84 | -0.78 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.